influenza
viru
infect
acut
respiratori
diseas
caus
high
morbid
mortal
repres
import
threat
public
health
activ
host
antivir
innat
adapt
immun
respons
typic
result
selflimit
diseas
nevertheless
clear
influenza
viru
infect
still
caus
high
morbid
mortal
infect
individu
hallmark
mani
fatal
case
influenza
infect
develop
exacerb
lung
immunopatholog
caus
unbalanc
immun
respons
therefor
respons
need
reach
balanc
effect
elimin
invad
viru
avoid
develop
immunemedi
patholog
lung
although
caus
immunopatholog
excess
product
cytokin
infiltr
inflammatori
cell
report
influenza
viru
infect
mechan
share
antivir
host
defens
requir
viral
clearanc
requir
develop
immunopatholog
clearli
understood
purinerg
receptor
trimer
ligandg
ion
channel
activ
extracellular
atp
constitut
express
mani
cell
type
includ
respiratori
epitheli
cell
immun
cell
neutrophil
monocytesmacrophag
dendrit
cell
natur
killer
cell
b
lymphocyt
activ
receptor
extracellular
atp
play
central
role
induct
inflamm
exampl
trigger
releas
proinflammatori
cytokin
includ
prompt
activ
inflammasom
product
reactiv
oxygen
speci
induct
apoptosi
role
purinerg
signal
viru
infect
demonstr
use
differ
model
hiv
infect
activ
pathway
import
celltocel
infect
releas
infecti
particl
infect
macrophag
studi
peripher
blood
mononuclear
cell
pbmc
hepat
c
virusinfect
patient
show
upregul
correl
sustain
antivir
respons
treatment
human
pbmc
infect
dengu
viru
activ
purinerg
signal
modul
immun
respons
reduc
viru
replic
kill
infect
cell
cell
final
mice
lack
ko
mice
increas
surviv
adenoviru
infect
compar
wildtyp
wt
mice
studi
suggest
activ
purinerg
signal
may
import
immun
respons
influenza
viru
infect
partial
reduct
secret
observ
bone
marrowderiv
macrophag
dendrit
cell
virusinfect
ko
mice
indic
possibl
role
receptor
activ
differ
studi
use
tumor
necrosi
factor
alpha
receptor
ko
mice
observ
influenza
viru
infect
mrna
level
lower
mice
suggest
role
pathway
signal
infect
addit
level
extracellular
atp
ligand
increas
lung
airway
influenza
viru
infect
determin
possibl
contribut
pathway
induct
exacerb
immun
respons
influenza
viru
infect
test
surviv
cytokin
product
leukocyt
infiltr
lung
patholog
infect
ko
mice
compar
wildtyp
mice
overal
ko
mice
reduc
inflammatori
respons
lung
lower
degre
lesion
develop
result
increas
surviv
determin
whether
activ
effect
influenza
viru
growth
test
addit
bbg
brilliant
blue
g
antagonist
oxi
methyl
propyl
az
antagonist
bzatp
atp
triethylammonium
agonist
cell
cultur
infect
first
confirm
immunofluoresc
confoc
microscopi
cell
express
receptor
fig
one
hour
infect
influenza
apuerto
viru
pandem
viru
cell
treat
bbg
bzatp
signific
differ
observ
viru
growth
cell
treat
bbg
bzatp
compar
untreat
cell
p
fig
observ
signific
reduct
viru
titer
cell
pretreat
az
infect
h
h
postinfect
compar
untreat
cell
p
fig
cell
infect
viru
treat
bbg
bzatp
signific
differ
observ
viru
growth
fig
cell
pretreat
az
infect
viru
observ
signific
reduct
viru
titer
h
postinfect
compar
untreat
cell
p
fig
activ
associ
increas
sustain
inflammatori
respons
determin
whether
pathway
relat
exacerb
lung
immunopatholog
develop
influenza
viru
infect
test
mice
lack
mous
model
influenza
viru
infect
infect
viru
observ
signific
reduct
bodi
weight
day
postinfect
wildtyp
wt
mice
p
fig
also
observ
increas
surviv
virusinfect
ko
mice
compar
wildtyp
mice
p
fig
similarli
wildtyp
mice
infect
viru
observ
signific
reduct
bodi
weight
day
postinfect
p
fig
signific
increas
surviv
observ
infect
ko
mice
compar
infect
wildtyp
mice
p
fig
amount
replic
viru
lung
thought
correl
degre
lung
patholog
therefor
infect
wildtyp
ko
mice
viru
day
infect
lung
harvest
viral
titer
determin
plaqu
assay
reduc
viru
titer
observ
lung
ko
mice
compar
wildtyp
mice
particularli
sampl
collect
day
postinfect
although
differ
statist
signific
p
fig
differ
set
mice
lung
collect
day
postinfect
repres
section
prepar
histopatholog
group
mice
lesion
character
bronchointerstiti
pneumonia
although
sever
lesion
differ
group
p
tabl
lung
virusinfect
ko
mice
bronchiolar
region
show
mild
moder
epitheli
degener
character
vacuol
multifoc
necrosi
individu
epitheli
cell
thin
layer
peribronchiolar
inflammatori
cell
moder
perivascular
inflamm
littl
presenc
intralumin
debri
fig
bronchiolar
region
lung
wildtyp
mice
exhibit
mark
epitheli
degener
character
vacuol
segment
necrosi
loss
epithelium
thick
layer
peribronchiolar
inflammatori
cell
mild
mark
amount
intralumin
debri
fig
alveolar
level
lesion
ko
mice
consist
mild
inflamm
well
tissu
damag
character
presenc
scatter
cell
necrosi
mild
moder
infiltr
inflammatori
cell
fig
alveolar
region
lung
wildtyp
mice
exhibit
mark
alveolar
inflamm
character
multifoc
necrosi
mark
infiltr
inflammatori
cell
fig
signal
receptor
induc
cell
apoptosi
activ
caspas
cascad
includ
determin
level
apoptosi
infect
influenza
quantifi
number
cleav
immunoreact
cell
lung
ko
wildtyp
mice
collect
day
postinfect
lung
section
alveolar
region
show
reduc
number
cleav
cell
sampl
obtain
virusinfect
ko
mice
compar
virusinfect
wt
mice
fig
b
quantif
confirm
number
cleav
cell
significantli
lower
lung
infect
ko
mice
p
fig
indic
reduc
amount
apoptosi
lung
mice
determin
whether
reduc
patholog
apoptosi
observ
lung
ko
mice
correl
decreas
cytokin
product
infect
first
quantifi
amount
cytokin
ex
vivoinfect
bone
marrowderiv
macrophag
bmdm
lung
virusinfect
ko
wt
mice
cultur
bmdm
obtain
ko
wt
mice
infect
viru
supernat
collect
h
postinfect
observ
increas
product
cxc
chemokin
ligand
time
point
supernat
infect
macrophag
obtain
wt
mice
p
fig
statist
differ
observ
cytokin
tumor
necrosi
factor
alpha
cc
chemokin
ligand
although
trend
signific
observ
amount
sampl
collect
h
postinfect
p
vivo
experi
first
infect
set
mice
ko
wt
influenza
viru
day
postinfect
collect
lung
sera
amount
significantli
higher
lung
wt
mice
lung
ko
mice
p
fig
trend
signific
observ
amount
lung
ko
mice
compar
lung
wt
mice
p
fig
similar
result
observ
mice
infect
differ
influenza
viru
significantli
larger
amount
lung
wt
mice
see
fig
supplement
materi
evalu
myeloid
cell
popul
whole
lung
ko
wt
mice
infect
viru
collect
day
day
postinfect
pi
observ
higher
number
macrophag
lung
virusinfect
ko
mice
time
point
compar
virusinfect
wt
mice
p
fig
signific
differ
absolut
number
cell
mockinfect
virusinfect
wt
ko
sampl
evalu
leukocyt
popul
bronchoalveolar
lavag
fluid
balf
ko
wt
mice
day
postinfect
viru
total
number
cell
viabil
balf
differ
group
percentag
activ
macrophag
significantli
increas
day
pi
ko
mice
wt
mice
p
day
pi
fig
percentag
neutrophil
balf
sampl
significantli
higher
day
pi
wt
mice
ko
mice
fig
p
differ
group
observ
day
pi
significantli
higher
percentag
activ
lymphocyt
observ
ko
mice
day
pi
p
fig
differ
percentag
activ
lymphocyt
observ
group
day
pi
percentag
lyse
cell
balf
wt
mice
tend
higher
especi
day
pi
p
fig
mechan
immun
respons
balanc
achiev
influenza
viru
clearanc
tissu
repair
versu
harm
immunopatholog
well
understood
studi
show
mice
lack
purinerg
receptor
better
clinic
outcom
influenza
viru
infect
character
increas
surviv
rate
overal
reduc
immunopatholog
lung
compar
wildtyp
mice
atp
main
ligand
receptor
usual
locat
intracellularli
although
small
amount
found
extracellular
space
cell
stress
damag
infect
atp
releas
extracellular
space
rapidli
bind
excitatori
receptor
promot
inflammatori
respons
activ
purinerg
pathway
encompass
seri
inflammationrel
respons
includ
activ
prolifer
recruit
immun
cell
well
secret
divers
inflammatori
mediat
includ
cytokin
chemokin
initi
evalu
done
vitro
infect
cell
treat
differ
agonist
antagonist
influenza
viru
infect
determin
impact
viru
growth
observ
differ
cell
treat
antagonist
az
potent
cyclic
imid
inhibitori
concentr
nm
select
inhibit
human
contrast
bbg
antagonist
use
studi
moder
select
less
potent
block
human
nm
sinc
treat
cell
concentr
compound
specul
differ
potenc
may
one
reason
observ
effect
viru
growth
one
receptor
antagonist
vivo
studi
first
observ
mice
lack
receptor
ko
mice
better
surviv
infect
surviv
independ
viru
strain
use
gener
accept
surviv
infect
host
correl
reduct
viral
burden
lung
howev
quantifi
viru
titer
lung
infect
mice
observ
viru
titer
lung
virusinfect
ko
mice
significantli
differ
lung
virusinfect
wildtyp
mice
lack
correl
lung
viru
titer
sever
diseas
previous
report
earli
stage
viral
infect
influenza
viru
iav
activ
antiapoptot
signal
evad
host
defens
mechan
howev
later
stage
infect
iav
trigger
apoptosi
activ
intrins
pathway
order
achiev
enhanc
viral
replic
dissemin
contribut
tissu
damag
evalu
apoptosi
lung
day
postinfect
consid
late
infect
observ
reduc
number
apoptot
cell
ko
mice
apoptosi
occur
mani
mechan
includ
product
proinflammatori
cytokin
lead
increas
burden
apoptosi
alveolar
epithelium
activ
caspas
cascad
includ
format
releas
reactiv
oxygen
speci
interest
activ
receptor
induc
aforement
proapoptot
mechan
therefor
absenc
receptor
caus
reduct
apoptosi
later
stage
infect
extent
sever
damag
observ
lung
tissu
virusinfect
wt
mice
due
cytolyt
effect
viru
infect
immunopatholog
caus
immun
cell
target
infect
cell
find
signific
differ
lung
viru
titer
virusinfect
ko
wt
mice
therefor
reduc
histopatholog
apoptosi
observ
ko
mice
point
toward
differ
immunemedi
patholog
influenza
viru
infect
increas
product
proinflammatori
cytokin
posit
correl
sever
diseas
human
especi
infect
highli
virul
strain
viru
recent
pandem
patient
sever
diseas
also
high
level
proinflammatori
cytokin
similar
correl
observ
anim
model
influenza
viru
infect
mous
model
influenza
mice
sever
clinic
sign
succumb
infect
increas
level
proinflammatori
cytokin
chemokin
lung
develop
lung
immunopatholog
studi
observ
virusinfect
ko
mice
lower
level
proinflammatori
cytokin
lung
day
postinfect
activ
receptor
extracellular
atp
play
central
role
releas
proinflammatori
cytokin
play
role
regul
macrophag
neutrophil
effector
cell
import
cell
mediat
inflamm
therefor
lower
level
cytokin
observ
lung
ko
mice
influenza
viru
infect
may
explain
lack
activ
purinerg
signal
pathway
mice
observ
level
lung
ko
mice
infect
lower
wt
mice
consid
antiinflammatori
cytokin
context
influenza
viru
infect
product
relat
reduc
immunopatholog
increas
surviv
discrep
may
explain
time
measur
lung
sinc
main
contributor
product
context
influenza
infect
effector
cell
popul
cell
found
later
infect
addit
increas
level
cytokin
earli
infect
hinder
activ
antivir
immun
respons
suggest
increas
level
observ
wt
mice
earli
infect
may
detriment
suppress
cytokin
product
site
infect
use
drug
mice
specif
cytokin
knock
enough
confer
full
protect
lethal
influenza
viru
infect
lack
receptor
model
induc
global
reduct
cytokin
product
influenza
viru
infect
sinc
observ
differ
cytokin
level
serum
virusinfect
ko
wt
mice
also
measur
basal
level
lung
naiv
ko
wt
mice
signific
differ
observ
see
fig
supplement
materi
togeth
result
suggest
reduc
histopatholog
increas
surviv
observ
ko
mice
infect
part
due
protect
immun
respons
site
infect
rather
ablat
respons
local
increas
cytokin
stimul
infiltr
neutrophil
well
monocyt
peripheri
essenti
step
resolut
viru
infect
studi
observ
reduct
neutrophil
influx
airway
ko
mice
day
postinfect
also
evid
analysi
lung
histolog
section
exacerb
respons
increas
influx
highli
proinflammatori
neutrophil
prolong
activ
cell
lead
increas
tissu
damag
lethal
purinerg
signal
presenc
high
concentr
extracellular
atp
critic
role
activ
neutrophil
product
cytokin
increas
influx
persist
neutrophil
site
infect
furthermor
observ
significantli
smaller
amount
lung
ko
mice
infect
influenza
viru
chemokin
import
factor
chemotaxi
activ
increas
oxid
burst
neutrophil
high
level
respiratori
tract
influenza
viru
infect
correl
enhanc
pulmonari
immunopatholog
togeth
result
suggest
purinerg
signal
receptor
import
recruit
possibl
activ
neutrophil
lung
influenza
viru
infect
observ
increas
influx
activ
macrophag
airway
space
ko
mice
compar
wt
group
addit
flow
cytometri
analysi
lung
virusinfect
mice
show
increas
number
macrophag
inflammatori
macrophag
ko
mice
compar
wt
mice
cell
proinflammatori
immunomodulatori
base
cytokin
profil
produc
surfac
marker
express
activ
lung
accumul
inflammatori
macrophag
immunoregulatori
phenotyp
contribut
reduc
develop
immunopatholog
furthermor
shown
mainten
cell
popul
longer
time
site
infect
correl
protect
mice
influenzainduc
immunopatholog
lethal
role
receptor
activ
macrophag
previous
establish
vivo
ex
vivo
vitro
activ
pathway
import
releas
proinflammatori
cytokin
increas
cation
flux
respiratori
burst
inhibit
phagocytosi
apoptosi
differ
popul
macrophag
result
indic
number
immun
cell
infiltr
lung
infect
determin
develop
exacerb
respons
lead
immun
patholog
perhap
import
type
activ
statu
cell
recruit
site
infect
histopatholog
analysi
lung
section
clearli
show
increas
number
infiltr
cell
lung
parenchyma
virusinfect
wildtyp
mice
compar
virusinfect
ko
mice
howev
analysi
infiltr
cell
show
number
macrophag
whole
lung
number
activ
macrophag
balf
associ
protect
higher
virusinfect
ko
mice
furthermor
activ
receptor
modifi
protein
secret
profil
stimul
macrophag
depend
activ
statu
cell
proinflammatori
immunomodulatori
provid
evid
activ
pathway
may
function
fine
tune
activ
heterogen
popul
macrophag
observ
infect
lung
activ
purinerg
receptor
signal
increas
level
extracellular
atp
caus
influenza
viru
infect
lead
exacerb
immun
respons
character
increas
product
proinflammatori
cytokin
induct
apoptosi
increas
influx
neutrophil
airway
develop
lung
histopatholog
respons
like
produc
amplifi
influenza
virusinduc
immunopatholog
lead
increas
morbid
mortal
infect
mice
contrari
effect
moder
ko
mice
result
better
outcom
infect
studi
demonstr
import
role
receptor
develop
lung
immunopatholog
influenza
viru
infect
result
contribut
better
understand
immun
respons
may
direct
caus
immunopatholog
observ
influenza
infect
furthermor
understand
role
receptor
activ
immun
respons
open
opportun
develop
medic
intervent
aim
modul
host
respons
toward
balanc
immun
respons
clear
viru
minimum
lung
damag
adenocarcinom
human
alveolar
basal
epitheli
cell
cell
atcc
manassa
va
evalu
determin
presenc
purinerg
receptor
cell
cultur
cover
glass
fix
buffer
formalin
later
incub
nonfat
milk
min
block
step
cell
incub
polyclon
receptor
antibodi
rais
rabbit
origen
rockvil
md
detect
antibodi
cell
incub
antirabbit
alexa
fluor
antibodi
thermo
fisher
scientif
waltham
mount
medium
contain
dapi
vector
laboratori
burlingam
ca
ad
cell
analysi
studi
effect
purinerg
receptor
agonist
antagonist
viru
growth
cell
treat
brilliant
blue
g
bbg
sigmaaldrich
st
loui
mo
oxi
methyl
propyl
az
tocri
bristol
unit
kingdom
bbg
receptor
antagonist
atp
trimethylammonium
bzatp
sigmaaldrich
st
loui
mo
receptor
agonist
cell
treat
bbg
bzatp
h
infect
influenza
apuerto
influenza
viru
infect
viru
remov
medium
respect
compound
ad
cell
supernat
collect
h
postinfect
sampl
store
titrat
perform
standard
plaqu
assay
madindarbi
canin
kidney
mdck
cell
research
studi
involv
use
anim
review
approv
institut
anim
care
use
committe
iacuc
icahn
school
medicin
mount
sinai
studi
carri
strict
accord
recommend
guid
care
use
laboratori
anim
femal
receptor
knockout
mice
week
old
purchas
jackson
laboratori
bar
harbor
use
experi
viru
challeng
mice
anesthet
intraperiton
inject
mixtur
ketamin
mgkg
bodi
weight
xylazin
mgkg
intranas
administr
lethal
dose
influenza
viru
volum
anim
monitor
daili
clinic
sign
ill
bodi
weight
record
daili
day
upon
reach
initi
bodi
weight
anim
human
euthan
day
postinfect
group
mice
euthan
lung
collect
homogen
beadblast
benchmark
scientif
ml
steril
phosphatebuff
salin
pb
lung
homogen
spun
g
min
pellet
tissu
debri
supernat
collect
sampl
store
titrat
perform
standard
plaqu
assay
mdck
cell
mice
euthan
day
postinfect
lung
perfus
situ
ml
buffer
formalin
lung
section
stain
hematoxylineosin
evalu
experienc
compar
pathologist
center
compar
medicin
surgeri
icahn
school
medicin
mount
sinai
follow
score
system
scale
use
analyz
histopatholog
lung
section
lesion
mild
chang
scatter
cell
necrosisvacuol
fewscatt
inflammatori
cell
bronchiolar
epithelium
minim
perivascular
inflamm
moder
multifoc
vacuol
peribronchiolar
inflamm
cell
layer
thick
mark
multifocalsegment
necrosi
epitheli
losseffac
peribronchiolar
inflamm
cell
layer
thick
sever
coalesc
area
necrosi
parenchym
effac
confluent
area
inflamm
overal
patholog
score
per
group
use
statist
analysi
result
addit
section
process
immunohistochemistri
ihc
use
determin
amount
apoptosisrel
protein
tenmicronthick
deparaffin
section
subject
heatinduc
epitop
retriev
boil
mm
sodium
citrat
buffer
ph
min
follow
min
cooldown
cleav
antibodi
cell
signal
technolog
inc
beverli
dilut
follow
buffer
pb
wtvol
bovin
serum
albumin
bsa
wtvol
sodium
azid
wtvol
nethylmaleimid
volvol
glycerol
antibodi
specif
recogn
larg
fragment
kda
activ
protein
cleav
fulllength
cleav
cell
count
print
digit
imag
use
transpar
templat
rectangular
box
measur
mm
mm
photograph
taken
magnif
three
differ
field
individu
blind
experiment
treatment
complet
quantif
bone
marrowderiv
macrophag
bmdm
gener
cultur
total
bone
marrow
femur
tibia
receptor
ko
wildtyp
mice
previous
describ
collect
cell
plate
densiti
cellswel
sixwel
plate
use
highglucos
dulbecco
modifi
eagl
medium
dmem
supplement
fetal
bovin
serum
fb
mm
penicillinstreptomycin
mm
sodium
pyruv
mm
hepe
cell
condit
supernat
contain
macrophag
colonystimul
factor
mcsf
cell
cultur
day
medium
nonadher
cell
remov
fresh
medium
ad
everi
day
harvest
day
cell
purifi
adher
harvest
cell
use
trypsin
infect
studi
cell
plate
plate
infect
influenza
viru
multipl
infect
moi
h
supernat
sampl
collect
h
postinfect
analyz
viru
titer
cytokin
product
protein
level
cytokineschemokin
evalu
use
multiplex
bead
array
assay
milliplex
emd
millipor
billerica
cell
cultur
supernat
bone
marrowderiv
macrophag
infect
influenza
lung
homogen
serum
sampl
mice
infect
influenza
viru
accord
manufactur
instruct
assay
run
use
bead
per
set
cytokin
measur
per
well
total
volum
plate
read
luminex
magpix
platform
bead
set
bead
collect
median
fluoresc
intens
bead
record
use
analysi
milliplex
softwar
use
regress
algorithm
mice
euthan
intraperiton
administr
pentobarbit
indic
time
point
lung
isol
hbss
buffer
sigma
st
loui
mo
digest
type
iv
collagenas
worthington
biochem
lakewood
nj
min
agit
process
singlecel
suspens
forc
digest
lung
nylon
cell
strainer
falcon
corn
ny
singlecel
suspens
stain
pb
supplement
bovin
serum
albumin
mm
edta
antibodi
follow
immun
marker
use
discrimin
immun
cell
type
bd
biolegend
bd
ebiosci
ebiosci
major
histocompat
complex
class
ii
mhcii
bd
siglecf
bd
live
cell
discrimin
dead
cell
use
viabil
dye
efluor
ebiosci
flow
cytometri
data
acquir
lsrii
flow
cytomet
bd
analyz
use
flowjo
softwar
flowjo
lcc
ashland
cell
sort
perform
fac
aria
bd
mice
euthan
intraperiton
administr
pentobarbit
indic
time
point
leukocyt
recruit
airway
space
collect
lavag
lung
situ
slowli
inject
ml
cold
steril
pb
use
input
syring
threeway
stopcock
approxim
ml
bronchoalveolar
lavag
fluid
balf
collect
lung
use
output
syring
repeat
procedur
three
time
cell
number
cell
viabil
determin
use
trypan
blue
automat
cell
counter
countess
ii
thermo
fisher
scientif
waltham
cytospin
balf
sampl
contain
cell
spun
rpm
min
slide
air
dri
h
stain
diffquick
slide
evalu
blind
manner
train
compar
pathologist
differenti
cell
count
percentag
establish
count
least
cell
high
magnif
use
follow
categor
undifferenti
alveolar
macrophag
defin
rel
larg
round
oval
cell
eccentr
round
oval
nuclei
abund
granular
cytoplasm
activ
macrophag
larger
contain
cytoplasm
numer
cytoplasm
vacuol
macrophag
binucl
neutrophil
diamet
character
eosinophil
cytoplasm
basophil
lobul
nucleu
violet
granul
inactiv
lymphocyt
small
cell
round
nuclei
dens
nuclear
chromatin
littl
cytoplasm
activ
reactiv
lymphocyt
larger
basophil
cytoplasm
eccentr
nuclei
final
also
quantifi
percentag
lyse
cell
rel
proport
isol
nake
nuclei
statist
differ
viru
titer
cytokin
product
ko
wt
mice
analyz
use
student
test
analysi
follow
holmsidak
test
analysi
surviv
rate
kaplanmei
curv
compar
use
log
rank
mantelcox
test
analysi
flow
cytometri
result
use
twoway
analysi
varianc
follow
multipl
comparison
use
tukey
posttest
error
bar
indic
standard
error
mean
p
valu
consid
signific
analys
perform
use
graphpad
softwar
la
jolla
ca
